Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charles River Laboratories Intl. Inc (CRL) vs Workday Inc (WDAY) Price & Performance

Charles River Laboratories Intl. IncTrade
Workday IncTrade

Price performance (Past 24H)

Key statistics

Charles River Laboratories Intl. Inc vs Workday Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $228.11 (market cap $11.14B), while Workday Inc trades at $143.28 (market cap $34.53B). The key difference: Workday Inc is far larger — about 3.1× Charles River Laboratories Intl. Inc's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Workday Inc nearer its low. Which is the better fit depends on your goals.

CRLWDAY
Market Cap
$11.14B$34.53B
Sector
HealthTechnology
52-Week High
$233.60$247.69
52-Week Low
$145.57$112.55
Enterprise Value
$14.00B$33.98B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Charles River Laboratories Intl. Inc

Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.

Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.

Workday Inc

Workday (WDAY) is trading at $144.87, up 4.26% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with consistent earnings beats, 14.7% YoY subscription revenue growth, and expanding AI-driven contract values exceeding 200% year-over-year. Analyst consensus remains strongly positive with 55.55% buy ratings and a $157.30 price target, representing 8.6% upside potential from current levels.

WDAY presents a compelling growth opportunity with AI integration driving larger expansion deals and sustainable revenue growth. However, investors face risks including ongoing AI bias litigation, competitive pressures in enterprise software, and elevated valuation multiples. The stock's current technical overbought condition suggests potential near-term consolidation before further upside.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Charles River Laboratories Intl. Inc

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Read more on CRL

About Workday Inc

Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions. Known for being a cloud-only software provider, Workday is headquartered in Pleasanton, California. Founded in 2005, Workday now employs over 12,000 employees.

Read more on WDAY